Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer ...Middle East

Medscape - News
Long-term follow-up data show a continued benefit in advanced hepatocellular carcinoma (HCC) with nivolumab and ipilimumab after disease progression on sorafenib in the Checkmate 040 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer )

Apple Storegoogle play

Also on site :

Most viewed in News